Effects of magnetic field strength and particle aggregation on relaxivity of ultra-small dual contrast iron oxide nanoparticles
Authors:
- 1 November 2017
- journal article
- research article
- Published by IOP Publishing in Materials Research Express
- Vol. 4 (11) , 116105
Abstract
No abstract availableKeywords
Funding Information
- Australian Research Council (CE140100036)
- National Natural Science Foundation of China (81471657)
- University of Queensland (UQECR1606713)
- Australian National Health and Medical Research Council (APP1037310)
This publication has 44 references indexed in Scilit:
- Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrastBiomaterials, 2017
- Molecular MRI of AtherosclerosisMolecules, 2013
- Magnetic nanoclusters with hydrophilic spacing for dual drug delivery and sensitive magnetic resonance imagingJournal of Materials Chemistry B, 2012
- Ultrasmall Water‐Soluble and Biocompatible Magnetic Iron Oxide Nanoparticles as Positive and Negative Dual Contrast AgentsAdvanced Functional Materials, 2012
- Large-Scale Synthesis of Uniform and Extremely Small-Sized Iron Oxide Nanoparticles for High-Resolution T1 Magnetic Resonance Imaging Contrast AgentsJournal of the American Chemical Society, 2011
- Multifunctional Magnetic Nanoparticles: Design, Synthesis, and Biomedical ApplicationsAccounts of Chemical Research, 2009
- Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?Kidney International, 2009
- Synergistically Integrated Nanoparticles as Multimodal Probes for NanobiotechnologyAccounts of Chemical Research, 2008
- Imaging in the era of molecular oncologyNature, 2008
- Nanoparticle PET-CT Imaging of Macrophages in Inflammatory AtherosclerosisCirculation, 2008